Scientists are testing an experimental anti-amyloid antibody in people expected to develop early-onset Alzheimer's.

The finding may open a whole new world in the study of Alzheimer's disease, said biophysicist Aneta Stefanovska.

The Washington University trial comes as part of a larger platform study, which hopes to understand whether the disease can ...

Explore the potential of monoclonal antibodies in Alzheimer’s treatment, including breakthroughs and challenges in this ...

Dementia affects millions of people all over the world, and that number continues to increase every year—by more than 9.9 ...

The first participants in an international clinical trial aimed at preventing Alzheimer’s disease in young adults at high ...

A study confirms the positive effects of exercise on insulin signaling proteins in the brain. A study led by researchers ...

Children who inherit genetic mutations from parents with early-onset Alzheimer’s typically show signs of dementia at the same ...

Recent studies reveal how the timing of dreams may offer clues to Alzheimer's risk. How sleep patterns impact cognitive health and prevention.

The trial, led by Washington University School of Medicine in St. Louis, aims to determine whether stopping the early molecular changes that lead to symptomatic Alzheimer's disease can prevent the ...

Are concerns about sleeping pills being linked to dementia based on evidence? Many people need help getting to, or staying, ...